AU Stock MarketDetailed Quotes

OSPDA Osprey Medical Inc

Watchlist
  • 0.830
  • 0.0000.00%
20min DelayTrading Sep 23 16:00 AET
42.59MMarket Cap-1040P/E (Static)

Osprey Medical Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2020
(FY)Dec 30, 2019
(FY)Dec 30, 2018
Total revenue
-54.38%1.67M
45.78%3.67M
2.51M
Operating revenue
-54.38%1.67M
45.78%3.67M
--2.51M
Cost of revenue
-30.78%1.22M
27.71%1.77M
1.38M
Gross profit
-76.38%448.18K
67.92%1.9M
1.13M
Operating expense
-30.75%14.14M
5.98%20.42M
19.26M
Selling and administrative expenses
-36.91%9.2M
8.47%14.57M
--13.44M
-Selling and marketing expense
-46.45%5.73M
7.13%10.7M
--9.99M
-General and administrative expense
-10.52%3.46M
12.37%3.87M
--3.45M
Research and development costs
-27.65%2.22M
-15.78%3.06M
--3.64M
Depreciation amortization depletion
8.49%301.68K
1.51%278.07K
--273.92K
-Depreciation and amortization
8.49%301.68K
1.51%278.07K
--273.92K
Other operating expenses
-3.00%2.43M
30.47%2.5M
--1.92M
Operating profit
26.07%-13.69M
-2.13%-18.52M
-18.13M
Net non-operating interest income (expenses)
Other net income (expenses)
-90.78%16.04K
-49.49%173.93K
344.32K
Other non-operating income (expenses)
-90.78%16.04K
-49.49%173.93K
--344.32K
Income before tax
25.98%-13.37M
-3.15%-18.07M
-17.51M
Income tax
154.00%5.28K
-239.99%-9.77K
6.98K
Earnings from equity interest net of tax
Net income
25.91%-13.38M
-3.05%-18.06M
-17.52M
Net income continuous operations
25.91%-13.38M
-3.05%-18.06M
---17.52M
Noncontrolling interests
Net income attributable to the company
25.91%-13.38M
-3.05%-18.06M
-17.52M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
25.91%-13.38M
-3.05%-18.06M
-17.52M
Diluted earnings per share
86.48%-0.565
16.40%-4.18
-5
Basic earnings per share
86.48%-0.565
16.40%-4.18
-5
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2020(FY)Dec 30, 2019(FY)Dec 30, 2018
Total revenue -54.38%1.67M45.78%3.67M2.51M
Operating revenue -54.38%1.67M45.78%3.67M--2.51M
Cost of revenue -30.78%1.22M27.71%1.77M1.38M
Gross profit -76.38%448.18K67.92%1.9M1.13M
Operating expense -30.75%14.14M5.98%20.42M19.26M
Selling and administrative expenses -36.91%9.2M8.47%14.57M--13.44M
-Selling and marketing expense -46.45%5.73M7.13%10.7M--9.99M
-General and administrative expense -10.52%3.46M12.37%3.87M--3.45M
Research and development costs -27.65%2.22M-15.78%3.06M--3.64M
Depreciation amortization depletion 8.49%301.68K1.51%278.07K--273.92K
-Depreciation and amortization 8.49%301.68K1.51%278.07K--273.92K
Other operating expenses -3.00%2.43M30.47%2.5M--1.92M
Operating profit 26.07%-13.69M-2.13%-18.52M-18.13M
Net non-operating interest income (expenses)
Other net income (expenses) -90.78%16.04K-49.49%173.93K344.32K
Other non-operating income (expenses) -90.78%16.04K-49.49%173.93K--344.32K
Income before tax 25.98%-13.37M-3.15%-18.07M-17.51M
Income tax 154.00%5.28K-239.99%-9.77K6.98K
Earnings from equity interest net of tax
Net income 25.91%-13.38M-3.05%-18.06M-17.52M
Net income continuous operations 25.91%-13.38M-3.05%-18.06M---17.52M
Noncontrolling interests
Net income attributable to the company 25.91%-13.38M-3.05%-18.06M-17.52M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 25.91%-13.38M-3.05%-18.06M-17.52M
Diluted earnings per share 86.48%-0.56516.40%-4.18-5
Basic earnings per share 86.48%-0.56516.40%-4.18-5
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data